Get 20% lifetime commission for referring investors to digrin.com
here.
Immunic, Inc. (IMUX) Financials
IMUX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 159.2 million | 31.6 million |
| March 31, 2026 | 189.7 million | 38.5 million |
| Dec. 31, 2025 | 24.1 million | 30.7 million |
| Sept. 30, 2025 | 40.7 million | 30.2 million |
IMUX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -31.2 million | 6.8 million |
| March 31, 2026 | -17.3 million | 4.5 million |
| Dec. 31, 2025 | -19.3 million | 1.3 million |
| Sept. 30, 2025 | -20.2 million | 3.6 million |
IMUX Net Income
No data available :(
IMUX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 155.1 million | 328000 | 239000 |
| March 31, 2026 | 186.6 million | - | 421000 |
| Dec. 31, 2025 | 15.5 million | 107000 | 107000 |
| Sept. 30, 2025 | 35.1 million | - | 792000 |
IMUX Shares Outstanding
IMUX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 249000 | 25.9 million | 9.4 million | - |
| March 31, 2026 | 2000 | 25.6 million | 7.6 million | - |
| Dec. 31, 2025 | 11000 | 19.1 million | 4.3 million | - |
| Sept. 30, 2025 | 67000 | 20.0 million | 6.0 million | - |
IMUX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 33000 |
| Dec. 31, 2025 | - | 42000 |
| Sept. 30, 2025 | - | - |
IMUX
Price: $16.83
52 week price:
Earnings Per Share: -3.67 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 562646
Market Capitalization: 217.4 million